Glutamine deprivation confers immunotherapy resistance by inhibiting IFN-γ signaling in cancer cells
Glutamine metabolism is emerging as a target for improving immunotherapy efficacy. However, the outcomes remain inconclusive. Given that the tumor-intrinsic response to interferon-γ (IFN-γ) is a key determinant of immunotherapy efficacy, we investigated whether and how glutamine deprivation in cance...
Saved in:
Main Authors: | Zhiwei Yuan, Taiyan Yu, Xu Wang, Kelin Meng, Tianlai Wang, Boyu Wang, Yu Xi, Congjian Wang, Chenxi Zeng, Shaojie Hu, Yitao Tian, Hui Xiong, Qi Wang, Wenbin Zou, Xue Wang, Yi Gao, Xiangning Fu, Lequn Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Pharmacological Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1043661825000684 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimizing Microneutralization and IFN-γ ELISPOT Assays to Evaluate Mpox Immunity
by: Yinyi Yu, et al.
Published: (2024-12-01) -
Safety evaluation of the food enzyme protein‐glutamine γ‐glutamyltransferase from the non‐genetically modified Streptomyces mobaraensis strain AE‐BTG
by: EFSA Panel on Food Enzymes (FEZ), et al.
Published: (2024-12-01) -
Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets
by: Ding Nan, et al.
Published: (2025-01-01) -
RUNX2 enhances bladder cancer progression by promoting glutamine metabolism
by: Zhigang Huang, et al.
Published: (2025-02-01) -
Inhibition of BRD4 attenuated IFNγ-induced apoptosis in colorectal cancer organoids
by: Akimi Yonezawa, et al.
Published: (2025-01-01)